The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 80.
136. lappuse
... indicated , the court said “ Yes . ” The question as to whether a machine is " on sale " or in " public use " is frequently involved in the same case . What is the situation where a machine had been completed but was a demonstration ...
... indicated , the court said “ Yes . ” The question as to whether a machine is " on sale " or in " public use " is frequently involved in the same case . What is the situation where a machine had been completed but was a demonstration ...
346. lappuse
... indicate pre- dictability of the class of compounds claimed , and the disclosure of prior art ester examples would be insufficient to indicate such pre- dictability , does it follow that the prior art ester is not pertinent as a ...
... indicate pre- dictability of the class of compounds claimed , and the disclosure of prior art ester examples would be insufficient to indicate such pre- dictability , does it follow that the prior art ester is not pertinent as a ...
563. lappuse
... indicated that Ethyl could not insulate itself from the Ziegler - Hercules counterclaim by alleging patent misuse . As for the counterclaim itself the court ob- served that Ziegler's abortive attempt to grant Hercules an exclusive ...
... indicated that Ethyl could not insulate itself from the Ziegler - Hercules counterclaim by alleging patent misuse . As for the counterclaim itself the court ob- served that Ziegler's abortive attempt to grant Hercules an exclusive ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention